![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Friday, August 28, 2020 9:35:19 AM
Sent off questions yesterday to IR and received this back I address to Crabtree but don't believe he is the one answering these questions. Not sure who answered these
Pay attention to question 2 and its answer. This is why I say management has no idea whats going on or happening.
.
Mr Crabtree
Question 1. We received word from a poster that said Hildago consent form is waiting on a global doctor that’s on vacation. Hildago supposedly having trouble with the wording. Can you tell me if that’s a true statement you gave to another person.
Answer: Dr. Crabtree has no knowledge of that which you infer. To intimate that Dr. Hidalgo has trouble with the English language borders on the ludicrous.
Question 2. Also the SMMG PR put out about 3 weeks ago indicated that The coming week which would have been 2 plus weeks back that Hildago had to write consent form he and his staff. And we had to hire CMO which has been done and announced. Is the consent form not done and turned in.
Answer What consent form?
Question 3. Sir in all due respect the SH keep getting PR’s as soon as this done we file or soon as that done we file. There has been many of these since January 2020. Nothing gets filed. Why tell us those things when evidently things aren't ready to file yet. Don’t blame it on SMMG cause whatever they write would have to be ok’d by KW. They are pals. He’s writing what KW tells him to say.
Answer Mr. Waggoner does NOT have to ok articles written by SMMG. SMMG does NOT have to write what anyone else says.
Question 4. Now company has peddled a bunch of cheap shares for a penny or more. What was the thinking behind that. We seen earlier they had 4.9 million in bank from 10-K One other thing is why was 10-K late in reporting. Is our CFO overworked.
Answer Everyone in the Company works extremely hard all of the time!
Question 5. Last questioned in your opinion do you think the IND will be filed this year or are we possibly looking at 2021. I'm not asking a specific date... jus t a generalize question of YOUR OPINION.
Answer It will not be next year.
Investor Relations
23046 Avenida de la Carlota, Suite 600
Laguna Hills, California 92652
O 917.595.2856 | F 917.595.2851
]
Recent PMCB News
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 05/30/2024 08:05:04 PM
- Form SC 13D - General statement of acquisition of beneficial ownership • Edgar (US Regulatory) • 05/30/2024 08:05:03 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/23/2024 08:40:20 PM
- PharmaCyte Biotech Makes $7 Million Strategic Investment in MyMD, A Biopharmaceutical Company Focused on Inflammatory Disease • Business Wire • 05/21/2024 01:00:00 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 02/14/2024 08:38:38 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/06/2024 02:56:28 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 12/15/2023 10:25:52 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/24/2023 09:00:13 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/22/2023 10:02:21 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/22/2023 10:02:03 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/22/2023 10:01:45 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/22/2023 10:01:23 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/22/2023 10:01:06 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/22/2023 10:00:10 PM
- Form SC 13D - General statement of acquisition of beneficial ownership • Edgar (US Regulatory) • 11/22/2023 09:00:15 PM
- PharmaCyte Biotech Acquires $5 Million Stake in Emerging Women’s Health Innovator Femasys, Inc. • Business Wire • 11/15/2023 01:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/09/2023 10:25:09 PM
- PharmaCyte Biotech Provides Corporate Update on Cell-in-a-Box Technology • Business Wire • 10/31/2023 01:15:00 PM
- PharmaCyte Biotech Provides Corporate Update on Cell-in-a-Box Technology • Business Wire • 10/31/2023 01:15:00 PM
- Form S-3/A - Registration statement under Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 09/21/2023 09:04:07 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 09/18/2023 10:04:06 AM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 09/15/2023 09:00:03 PM
- Form S-3/A - Registration statement under Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 09/12/2023 01:56:25 AM
FEATURED Cannabix Technologies and Omega Laboratories Inc. Provide Positive Developments on Marijuana Breathalyzer Testing • Jul 11, 2024 8:21 AM
ECGI Holdings Enhances Board with Artificial Intelligence (AI) Expert Ahead of Allon Apparel Launch • ECGI • Jul 10, 2024 8:30 AM
Avant Technologies to Meet Unmet Needs in AI Industry While Addressing Sustainability Concerns • AVAI • Jul 10, 2024 8:00 AM
Panther Minerals Inc. Launches Investor Connect AI Chatbot for Enhanced Investor Engagement and Lead Generation • PURR • Jul 9, 2024 9:00 AM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM